The evolving need and challenges to reach LDL-c targets in high-risk patients
Video navigation menu
- Relevance of cholesterol to CVD mortality 00:28
- Estimating benefit of initiating LDL-c lowering at different ages 02:08
- Conceptual framework shift 03:53
- Data on LDL-c goal attainment and use of combination therapy 05:07
- Conclusions 08:50
This lecture by Prof. Kausik Ray was part of the EBAC-accredited symposium "The LDL-c challenge in high cardiovascular risk: Integrating innovative therapies in clinical management" held during the ESC congress 2023.
Prof. Kausik Ray, MD, is president of the European Atherosclerosis Society, and Professor of Public Health/ Consultant Cardiologist at Imperial College London, United Kingdom.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant from Amgen, NewAmsterdam Pharma, Sanofi and Viatris.